Net Cash Provided by (Used in) Operating Activities |
-289K |
USD |
-72.5% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
141M |
USD |
+19790% |
Dec 31, 2023 |
Q4 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Dec 31, 2022 |
Q4 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-289K |
USD |
-171% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
74.6K |
USD |
-92.4% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
716K |
USD |
+162% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
716K |
USD |
+162% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Federal Income Tax Expense (Benefit) |
-443K |
USD |
-155% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
2.31M |
USD |
+196% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |